Table 10.
Serum palivizumab concentrations (trough) over time (FAS).
| Time | Statistics |
||||||
|---|---|---|---|---|---|---|---|
| Number of subjects (number of non-missing data) | Mean | SD | Min | Median | Max | 95% CI (upper–lower) | |
| Visit 1 | 23 (23) | 10.00 | 0.00 | 10.0 | 10.0 | 10.0 | |
| Visit 2 | 23 (23) | 66.89 | 13.58 | 40.0 | 63.90 | 89.2 | (72.759–61.015) |
| 30 days after the fourth dose | 23 (23) | 116.82 | 32.60 | 49.5 | 114.00 | 167.0 | (130.916–102.719) |
| 30 days after the fifth dose | 4 (1) | 153.00 | 153.0 | 153.00 | 153.0 | ||
FAS, full analysis set. Data are shown in [μg/mL] unless otherwise stated.